Estrogen-containing medication, prescribed either for contraception in women of
reproductive age or for prevention of cardiovascular events and osteoporosis as well as for …

There is now compelling evidence that use of oral contraceptives and postmenopausal
hormonal therapies containing various estrogens is associated with a weak, but clinically …

Combined oral contraceptives and combined oral postmenopausal hormone therapy are
associated with a weak, but clinically significant risk of arterial and venous thrombosis (VT) …

Background Venous thromboses are well‐established complications of hormonal therapy.
Thrombosis risk is seen with both hormonal contraceptive agents and with hormone …

Hundreds of millions of women worldwide use either oral contraceptives or postmenopausal
hormone replacement. The use of oral contraceptives leads to an increased risk of venous …

The search for a safe and effective method of contraception has been ongoing for centuries.
During the last century, a variety of hormonal contraceptives, including combined hormonal …

Combined oral contraceptives, oral hormone replacement therapy and thrombophilias are
recognised risk factors for venous thromboembolism in women. The objective of this study …

During their lifetimes, women face several unique situations with an increased risk of venous
thromboembolism (VTE). Doctors in a variety of specialties must advise women on the risks …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

Hormonal contraceptives are a popular method of contraception, but their use has been
associated with an increased risk for venous thromboembolism. In order to reduce such risk …